<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03923153</url>
  </required_header>
  <id_info>
    <org_study_id>MustafaKU 2</org_study_id>
    <nct_id>NCT03923153</nct_id>
  </id_info>
  <brief_title>Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina</brief_title>
  <official_title>Effectiveness of Inspiratory Muscle Training in Patient With Stable Angina</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mustafa Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mustafa Kemal University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stable angina is a cardiac pathology that adversely affects the quality of life of the
      patient, which develops as a result of narrowing of the coronary vessels developing in
      atherosclerotic ground and / or impaired oxygen supply-need balance. Studies widely
      investigated the effects of exercise training in patients with stable angina. No study
      investigated the effects of inspiratory muscle training in patients with stable
      angina.Investigators aimed to investigate the effects of inspiratory muscle training on
      aerobic exercise capacity, quality of life, depression, peripheral and respiratory (MIP, MEP)
      muscle strength, pulmonary function, dyspnea, fatigue in stable angina patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with stable angina will be included. Primary outcome measurement is inspiratory
      muscle strength, secondary outcomes are functional exercise capacity, peripheral muscle
      strength, pulmonary functions, maximal exercise capacity, fatigue, quality of life,
      depression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">April 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the Inspiratory and expiratory muscle strength (MIP, MEP) from baseline to 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Mouth pressure device( MicroRPM, Micro Medical England)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Functional exercise capacity at 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>6 minute walking test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Pulmonary functions at 8 week</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatigue</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Change from baseline Fatigue Severity Scale (FSS) (Turkish version of scale) at 8 weeek.
Patient choose a number from 1 to 7 that indicates how much the patient agrees with each statement, where 1 indicates strong disagreement and 7 indicates strong agreement. A score of 4 or higher generally indicates severe fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>Baseline,after 8 week</time_frame>
    <description>Change from baseline Montgomery Asberg Depression Rating Scale (MADRS) (Turkish version of scale) at 8 week.
This assessment tool contains 10 items with a score from 0 to 6, thus the maximum score is 60. A higher score indicates a more severe depression.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality life</measure>
    <time_frame>Baseline, after 8 week</time_frame>
    <description>Change of baseline quality of life at 8 week .Short Form (SF-36) Health Survey (Turkish version of scale) The SF-36 is a 36 item questionnaire that measures eight multi-item dimensions of health: physical functioning (10 items) social functioning (2 items) role limitations due to physical problems (4 items), role limitations due to emotional problems (3 items), mental health (5 items), energy/vitality (4 items), pain (2 items), and general health perception (5 items). For each dimension item scores are coded, summed, and transformed on to a scale from 0 (worst possible health state measured by the questionnaire) to 100 (best possible health state).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Angina, Stable</condition>
  <arm_group>
    <arm_group_label>Inspiratory muscle training group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inspiratory muscle training group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham group received inspiratory muscle training (IMT) using POWERbreathe Classic threshold loading device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspiratory muscle training with PowerBreathe (IMT Technologies Ltd., Birmingham,England)</intervention_name>
    <description>Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 30% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.</description>
    <arm_group_label>Inspiratory muscle training group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham group with PowerBreathe (IMT Technologies Ltd., Birmingham, England)</intervention_name>
    <description>Treatment group II will receive inspiratory muscle endurance training (IMT) using threshold loading device (POWERbreathe Classic, IMT Technologies Ltd. Birmingham, England) at 10% of maximal inspiratory pressure (MIP).
The MIP will be measured at supervised session each week, and 30% of measured MIP value will be the new training workload.
The treatment group will train for 30 min-per/day, 7 days/week, for 8 weeks. Six sessions at home and 1 session will be performed at department.</description>
    <arm_group_label>Sham group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No contraindication for pulmonary physiotherapy

          -  Anjina patients who are clinically stable

          -  have no other disease that may affect respiratory function

          -  Individuals who have the good cooperation

        Exclusion Criteria:

          -  Patients under the age of 18

          -  Pregnancy

          -  Active infection

          -  Patients with known malignancies

          -  patients without consent

          -  known arrhythmia, dilated or hypertrophic cardiomyopathy, heart failure (EF &lt;40%)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aysel yıldız, assoc prof</last_name>
    <role>Study Director</role>
    <affiliation>Marmara University Faculty of Health Sciences</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Irem Hüzmeli, Msc</last_name>
    <role>Study Chair</role>
    <affiliation>hatay mustafa kemal university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oğuz Akkuş, assist prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>hatay mustafa kemal university Faculty of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fatih Yalçın, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>hatay mustafa kemal university Faculty of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aysel Yıldız, assoc prof</last_name>
    <phone>90 216 330 20 70</phone>
    <phone_ext>1321</phone_ext>
    <email>aysel.yildiz@marmara.edu.tr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Irem Hüzmeli, Msc</last_name>
    <phone>903262455516</phone>
    <phone_ext>15550</phone_ext>
    <email>fztirem@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hatay Mustafa Kemal University</name>
      <address>
        <city>Hatay</city>
        <state>Merkez</state>
        <zip>31010</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irem Hüzmeli, msc</last_name>
      <phone>903262455516</phone>
      <phone_ext>15550</phone_ext>
      <email>fztirem@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>oğuz akkuş, med. dr.</last_name>
      <phone>05326685870</phone>
      <email>oakkusfb@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Aysel Yıldız, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fatih Yalçın, med. dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Irem Hüzmeli, msc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>oğuz akkuş, med. dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Kellens I, Cannizzaro F, Gouilly P, Crielaard JM. [Inspiratory muscles strength training in recreational athletes]. Rev Mal Respir. 2011 May;28(5):602-8. doi: 10.1016/j.rmr.2011.01.008. Epub 2011 Apr 19. French.</citation>
    <PMID>21645830</PMID>
  </reference>
  <reference>
    <citation>Long L, Anderson L, Dewhirst AM, He J, Bridges C, Gandhi M, Taylor RS. Exercise-based cardiac rehabilitation for adults with stable angina. Cochrane Database Syst Rev. 2018 Feb 2;2:CD012786. doi: 10.1002/14651858.CD012786.pub2. Review.</citation>
    <PMID>29394453</PMID>
  </reference>
  <reference>
    <citation>American Thoracic Society/European Respiratory Society. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002 Aug 15;166(4):518-624.</citation>
    <PMID>12186831</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2019</study_first_posted>
  <last_update_submitted>April 19, 2019</last_update_submitted>
  <last_update_submitted_qc>April 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mustafa Kemal University</investigator_affiliation>
    <investigator_full_name>Irem Hüzmeli</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <keyword>inspiratory muscle trainig</keyword>
  <keyword>quality of life</keyword>
  <keyword>aerobic capacity</keyword>
  <keyword>depression</keyword>
  <keyword>fatique</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
    <mesh_term>Angina, Stable</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

